Soluble CD40 ligand levels during controlled ovarian hyperstimulation - A possible culprit of systemic inflammation

American Journal of Reproductive Immunology

Volumn 56, Issue 4, 2006, Pages 243-248

  Orvieto, Raoul ^a,b   Schachter, Benny ^c   Yulzari roll, Vered ^b,c   La Marca, Antonio ^d   Bar, Jacob ^b,c   Fisch, Benjamin ^b,c  

^a BARZILAI MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Androgens; CD40 ligand; COH; IVF; OHSS; Sex steroids

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ANGIOGENIC FACTOR; CD40 LIGAND; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN DERIVATIVE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; OBSERVATIONAL STUDY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SYSTEMIC DISEASE; TESTOSTERONE BLOOD LEVEL;

ADULT; CD40 LIGAND; FEMALE; GONADAL STEROID HORMONES; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33747885926     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00424.x     Document Type: Article

References (26)

1. Orvieto R, Ben-Rafael Z: OvarAan hyperstimulation syndrome: a new insight into an old enigma. J Soc Gynecol Invest 1998; 5: 110-113.
2. Orvieto R: Controlled ovarian hyperstimulation - an inflammatory state. J Soc Gynecol Invest 2004; 11: 424-426.
3. Orvieto R, Chen R, Ashkenazi J, Ben-Haroush A, Bar J, Fisch B: C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycle. Hum Reprod 2004; 19: 357-359.
4. Orvieto R, Schwartz A, Bar Hava I, Abir R, Ashkenazi J, La-Marca A, Ben-Rafael Z: Controlled ovarian hyperstimulation - a state of endothelial activation. Am J Reprod Immunol 2000; 44: 257-260.
5. Orvieto R, Ben Rafael Z, Schwartz A, Abir R, Fisch B, La-Marca A, Bar-Hava I: Soluble L-selectin levels during controlled ovarian hyperstimulation. Gynecol Endocrinol 2001; 15: 29-33.
6. American Society for Reproductive Medicine: Ovarian hyperstimulation syndrome. Fertil Steril 2003; 80: 1309-1314.
7. Neulen J, Yan Z, Raczek S, Weindel K, Keek C, Weich HA, Marme D, Breckwoldt M: Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995; 80: 1967-1971.
8. Denton MD, Reul RM, Dharnidharka VR, Fang JC, Ganz P, Briscoe DM: Central role for CD40/ CD40L (CD154) interactions in transplant rejection. Pediatr Transplant 1998; 2: 6-15.
9. Mach F, Schonbeck U, Fabunmi RP, Murphy C, Atkinson E, Bonnefoy JY, Graber P, Libby P: T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am J Pathol 1999; 154: 229-238.
10. van Kooten CA Banchereau J: CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996; 61: 1-77.
11. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998; 394: 200-203.
12. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human mRnocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993; 178: 669-674.
13. Grewal IS, Flavell RA: A central role of CD40 ligand in the regulation of CD41 T-cell responses. Immunol Today 1996; 17: 410-414.
14. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L: Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals. J Exp Med 1995; 182: 1857-1864.
15. Melter M, Reinders MEJ, Sho M, Pal S, Geehan C, Denton MD, Mukhopadhyay D, Briscoe DM: Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 2000; 96: 3801-3808.
16. Cumming DC, Wall SR: Non-sex hormone-binding globulin-bound testosterone as a marker for hyperandrogenism. J Clin Endocrinol Metab 1985; 61: 873-876.
17. Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA: The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98: 1047-1054.
18. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler EF, Offner H: Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004; 173:2227-2300.
19. Caulin-Glaser T, Watson CA, Pardi R, Brener JR: Effects of 17b-Estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996; 98: 36-42.
20. Bottomley MJ, Webb NJ, Watson CJ, Holt PJ, Freemont AJ, Brenchley PE: Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): Specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol 1999; 117: 171-176.
21. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocrine Rev 1997; 18: 4-25.
22. Orvieto R, Ben-Rafael Z, Abir R, Bar Hava I, Fisch B, Molad Y: Controlled ovarian hyperstimulation - a state of neutrophil activation. Am J Reprod Immunol 1999; 42: 288-291.
23. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS 1997; 79: 233-269.
24. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M: Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 1995; 55: 4140-4145.
25. Moulton KS, Melder RJ, Dharnidharka VR, Hardin-Young J, Jain RK, Briscoe DM: Angiogenesis in the hu-PBL-SCID model of human transplant rejection. Transplantation 1999; 67: 1626-1631.
26. Orvieto R, Leites T, Abir R, Bar J, Yoeli R, Feldberg D, Fisch B: Interleukin-2 production in whole blood cell cultures of women undergoing controlled ovarian hyperstimulation for assisted reproductive technology cycles. Am J Reprod Immunol 2003; 50: 220-223.